WG
SAGE

Winton Group’s Sage Therapeutics SAGE Stock Holding History

Winton Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,356
Closed -$812K – 1068
2023
Q1 		$812K Buy
19,356
+3,848
+25% +$165K 0.05% 514
2022
Q4 		$591K Buy
15,508
+370
+2% +$14.1K 0.04% 581
2022
Q3 		$593K Sell
15,138
-1,821
-11% -$70.4K 0.04% 590
2022
Q2 		$548K Buy
16,959
+3,287
+24% +$110K 0.03% 668
2022
Q1 		$453K Buy
13,672
+2,246
+20% +$84.4K 0.02% 710
2021
Q4 		$486K Sell
11,426
-26,922
-70% -$1.13M 0.03% 684
2021
Q3 		$1.7M Buy
38,348
+19,108
+99% +$876K 0.1% 256
2021
Q2 		$1.09M Buy
19,240
+10,408
+118% +$736K 0.06% 481
2021
Q1 		$661K Sell
8,832
-1,959
-18% -$161K 0.04% 716
2020
Q4 		$934K Sell
10,791
-39,886
-79% -$2.94M 0.07% 445
2020
Q3 		$3.1M Sell
50,677
-5,734
-10% -$291K 0.1% 314
2020
Q2 		$2.35M Buy
+56,411
New +$2.05M 0.06% 575
2020
Q1 		– Sell
-18,659
Closed -$1.35M – 1522
2019
Q4 		$1.35M Buy
18,659
+15,740
+539% +$1.94M 0.02% 945
2019
Q3 		$410K Buy
+2,919
New +$488K ﹤0.01% 1155
2019
Q1 		– Sell
-2,680
Closed -$257K – 1168
2018
Q4 		$257K Sell
2,680
-811
-23% -$92.8K 0.01% 717
2018
Q3 		$493K Buy
3,491
+689
+25% +$106K 0.01% 632
2018
Q2 		$439K Sell
2,802
-778
-22% -$122K 0.01% 674
2018
Q1 		$577K Buy
+3,580
New +$608K 0.02% 706

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Winton Group's SAGE Position: Q2 2023 in Review

Winton Group sold out of Sage Therapeutics (SAGE) in Q2 2023, closing a stake of 19,356 shares — an estimated $812K sold.

Winton Group first reported a position in SAGE in Q1 2018 and held it in 18 quarters. The position peaked at $3.1M in Q3 2020. 225 funds tracked by Wall St. Rank hold SAGE as of Q2 2023.

  • Winton Group reported no remaining Sage Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Winton Group sold 19,356 Sage Therapeutics shares in Q2 2023, an estimated $812K.
  • Winton Group first reported a position in Sage Therapeutics in Q1 2018 and held it in 18 quarters.
  • Winton Group's Sage Therapeutics position peaked at $3.1M in Q3 2020.
  • 225 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2023.

Based on Winton Group's 13F filing for Q2 2023, filed 14 Aug 2023.